Market Tracker

04/28 6:45pm ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.34
Delayed Data
As of 4:02pm ET
 -0.03 / -2.19%
Today’s Change
0.75
Today|||52-Week Range
2.50
+0.75%
Year-to-Date

Today’s Trading

Previous close1.37
Today’s open1.36
Day’s range1.34 - 1.38
Volume280,826
Average volume (3 months)480,419
Market cap$213.1M
Dividend yield--
Data as of 4:02pm ET, 04/28/2016

Growth & Valuation

Earnings growth (last year)+25.00%
Earnings growth (this year)+55.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.15%
P/E ratioNM
Price/Sales15.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VTAEVitae Pharmaceutical...+0.16+2.09%
FLKSFlex Pharma Inc-0.48-4.03%
IDRAIdera Pharmaceutical...-0.06-3.39%
MNOVMediciNova Inc-0.07-0.99%
Data as of 4:00pm ET, 04/28/2016

Financials

Last reporting dateApril 28, 2016
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$13.2M
Annual profit (last year)-$27.6M
Net profit margin-213.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ricardo J. Gonzalez
Chief Operating Officer
Jed Andrew Latkin
Corporate headquarters
Dublin, Ohio

Forecasts